Keyphrases
Proglucagon-derived Peptides
100%
Differential Processing
100%
Proglucagon
80%
Clinical Phenotype
40%
Rash
40%
Hyperinsulinemic Hypoglycemia
40%
Hyperglucagonemia
40%
Tumor
40%
Clinical Manifestations
20%
Gastrointestinal Dysfunction
20%
Anorexia
20%
Cell-like
20%
Older Women
20%
Constipation
20%
Glucagon-like
20%
Glucagon
20%
Hypoglycemia
20%
Young Males
20%
Biochemical Assessment
20%
Weight Loss
20%
Secreted Peptides
20%
Peptide Repertoire
20%
Biological Activity
20%
Phenotypic Heterogeneity
20%
GLP-2
20%
Enteroendocrine Cells
20%
Improved Diagnosis
20%
Amino Acid Metabolism
20%
Small Intestine
20%
Energy Homeostasis
20%
Gastrointestinal Function
20%
Proglucagon Processing
20%
Plasma Parameters
20%
Diagnosis Management
20%
Metabolizable Energy
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Diarrhea
20%
Nausea-vomiting
20%
Phenotypic Variation
20%
Clinical Management
20%
Biochemistry, Genetics and Molecular Biology
Somatostatin Analog
100%
Secretion (Process)
100%
Phenotypic Variation
50%
Glucagon
50%
Amino Acid Metabolism
50%
Homeostasis
50%
Blood Level
50%
Glucagon-Like Peptide-1
50%
Biological Activity
50%
Phenotypic Heterogeneity
50%
Medicine and Dentistry
Proglucagon
100%
Glucagonoma
100%
Pancreas Islet Cell Tumor
60%
Neoplasm
20%
Exanthem
20%
Hyperglucagonemia
20%
Somatostatin Derivative
20%
Secretion (Process)
20%
Constipation
10%
Phenotypic Variation
10%
Hypoglycemia
10%
Glucagon
10%
Functional Gastrointestinal Disorder
10%
Biological Activity
10%
Amino Acid Metabolism
10%
Glucagon Like Peptide 1
10%
Homeostasis
10%
Nausea and Vomiting
10%
Anorexia
10%
Diabetes Mellitus
10%
Clinical Management
10%
Diarrhea
10%
Glucagon Like Peptide 2
10%